| IV-15 Rebekka Fendt Evaluating the benefit of individual patient data for physiologically based pharmacokinetic (PBPK) simulations Thursday 15:25-16:50 |
| IV-15 Rebekka Fendt Evaluating the benefit of individual patient data for physiologically based pharmacokinetic (PBPK) simulations Thursday 15:25-16:50 |